SOX14 and embryonal carcinoma: These results demonstrated that SOX14 promoter is methylated in the cervical cancer cell line, particularly in regions encompassed by CpG islands 1 and 3, while in the embryonal carcinoma NT2/D1 cell line the SOX14 promoter has a lower methylation rate.